Treatment of Metastatic Melanoma with Lenvatinib + Anti-PD1
Clinical trial NCT06586580 · COMPLETED
Trial details
- NCT number
- NCT06586580
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-30
- Primary completion
- 2023-12-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.